These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 19117535)

  • 1. Peptides presented in vivo by HLA-DR in thyroid autoimmunity.
    Muixí L; Alvarez I; Jaraquemada D
    Adv Immunol; 2008; 99():165-209. PubMed ID: 19117535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroglobulin peptides associate in vivo to HLA-DR in autoimmune thyroid glands.
    Muixí L; Carrascal M; Alvarez I; Daura X; Martí M; Armengol MP; Pinilla C; Abian J; Pujol-Borrell R; Jaraquemada D
    J Immunol; 2008 Jul; 181(1):795-807. PubMed ID: 18566446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate major histocompatibility complex class II expression by thyroid follicular cells in thyroid autoimmune disease and by pancreatic beta cells in type I diabetes.
    Pujol-Borrell R; Todd I; Londei M; Foulis A; Feldmann M; Bottazzo GF
    Mol Biol Med; 1986 Apr; 3(2):159-65. PubMed ID: 3090400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyperinducibility of HLA class II expression of thyroid follicular cells from Graves' disease. A primary defect?
    Sospedra M; Obiols G; Babi LF; Tolosa E; Vargas F; Roura-Mir C; Lucas-Martin A; Ercilla G; Pujol-Borrell R
    J Immunol; 1995 Apr; 154(8):4213-22. PubMed ID: 7706756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathyroidal MHC class II antigen expression and thyroid autoimmunity.
    Davies TF; Piccinini LA
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):247-68. PubMed ID: 3319584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class II major histocompatibility complex and organ specific autoimmunity in man.
    Foulis AK
    J Pathol; 1986 Sep; 150(1):5-11. PubMed ID: 2946837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.
    Ishikawa N; Eguchi K; Ueki Y; Nakashima M; Shimada H; Ito K; Nagataki S
    Clin Exp Immunol; 1993 Nov; 94(2):363-70. PubMed ID: 7900942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DM and invariant chain are expressed by thyroid follicular cells, enabling the expression of compact DR molecules.
    Catálfamo M; Serradell L; Roura-Mir C; Kolkowski E; Sospedra M; Vives-Pi M; Vargas-Nieto F; Pujol-Borrell R; Jaraquemada D
    Int Immunol; 1999 Feb; 11(2):269-77. PubMed ID: 10069425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of IFNalpha-inducible genes and modulation of HLA-DR and thyroid stimulating hormone receptors in Graves' disease.
    Kuang M; Wang S; Wu M; Ning G; Yao Z; Li L
    Mol Cell Endocrinol; 2010 May; 319(1-2):23-9. PubMed ID: 20015465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetes.
    Li CW; Osman R; Menconi F; Concepcion ES; Tomer Y
    J Autoimmun; 2017 Jan; 76():1-9. PubMed ID: 27670087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.
    Hanafusa T; Pujol-Borrell R; Chiovato L; Russell RC; Doniach D; Bottazzo GF
    Lancet; 1983 Nov; 2(8359):1111-5. PubMed ID: 6138646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithyroid drugs inhibit in vivo HLA-DR expression in thyroid follicular cells in Graves' disease.
    Zantut-Wittmann DE; Tambascia MA; da Silva Trevisan MA; Pinto GA; Vassallo J
    Thyroid; 2001 Jun; 11(6):575-80. PubMed ID: 11442005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
    Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
    Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of HLA-DR alpha-chain messenger ribonucleic acid in normal and autoimmune human thyroid using in situ hybridization.
    Piccinini LA; Goldsmith NK; Schachter BS; Davies TF
    J Clin Endocrinol Metab; 1988 Jun; 66(6):1307-15. PubMed ID: 2453529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules.
    Falcioni F; Ito K; Vidovic D; Belunis C; Campbell R; Berthel SJ; Bolin DR; Gillespie PB; Huby N; Olson GL; Sarabu R; Guenot J; Madison V; Hammer J; Sinigaglia F; Steinmetz M; Nagy ZA
    Nat Biotechnol; 1999 Jun; 17(6):562-7. PubMed ID: 10385320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenetic relevance of HLA class II expressing thyroid follicular cells in nontoxic Goiter and in Graves' disease.
    Grubeck-Loebenstein B; Londei M; Greenall C; Pirich K; Kassal H; Waldhäusl W; Feldmann M
    J Clin Invest; 1988 May; 81(5):1608-14. PubMed ID: 3130398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of aberrant association of DM with MHC class II subunits in the absence of invariant chain.
    Neumann J; König A; Koch N
    Int Immunol; 2007 Jan; 19(1):31-9. PubMed ID: 17105964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3.
    Piesche M; Hildebrandt Y; Chapuy B; Wulf GG; Trümper L; Schroers R
    Vaccine; 2009 Jul; 27(34):4718-23. PubMed ID: 19446593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA class II transgenic mice mimic human inflammatory diseases.
    Mangalam AK; Rajagopalan G; Taneja V; David CS
    Adv Immunol; 2008; 97():65-147. PubMed ID: 18501769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of insulin-like growth factor I on HLA-DR antigen expression in cultured human thyrocytes: a component of the autoimmune process?].
    Aguayo J; Wohlik N; Pérez MV; Pineda G
    Rev Med Chil; 1994 Mar; 122(3):248-52. PubMed ID: 7809513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.